Becton, Dickinson and Company (BD) has launched its next generation diagnostic instrument for the quick detection of bacteria and antimicrobial resistance.
The new BD Phoenix M50 ID/AST system has the same mode of operation as the legacy BD Phoenix 100, delivering quick, accurate and cost-effective testing with a smaller footprint.
BD diagnostics systems president Dave Hickey said: "The small footprint of the BD Phoenix M50 system combined with its demonstrated speed, accuracy and efficiency makes the system an attractive solution for microbiology laboratories around the world.
"This launch reinforces the engagement of BD to become more relevant in ID/AST and intensifies its support to the fight against antimicrobial resistance."
Based on the BD Phoenix 100, the new system can detect current and emerging resistances, as well as the extended testing capabilities provided by BD Phoenix Emerge AST panel with 136 wells.
The Phoenix M50 ID/AST system is incorporated with materials and engineering techniques which ensures reliability and eliminates the requirement of preventative maintenance.
It is robust and offers multiple languages thereby enabling its broader application in laboratories across the globe.
The BD Phoenix M50 system can also integrate with a number of other analysers, such as the BD BACTEC and BD Bruker MALDI Biotyper systems, through BD EpiCenter middleware connectivity that facilitates data traceability and security, paperless workflow and flexible communication capabilities.